Compounds > stiripentol

Page last updated: 2024-08-23

stiripentol and Oxaluria, Primary

stiripentol has been researched along with Oxaluria, Primary in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	7 (87.50)	2.80

Authors

Authors	Studies
Diaz-Gavilan, M; Fernandes, MX; Franco-Montalban, F; Gomez-Vidal, JA; Martin-Higueras, C; Moya-Garzon, MD; Pey, AL; Rodriguez-Rodriguez, B; Salido, E	1
Anglicheau, D; Chauvet, S; Chavarot, N; Isnard, P; Karras, A; Lombardi, Y; Martinez, F; Thervet, É	1
Drüeke, TB; Wyatt, CM	1
Bufler, P; Holle, J; Kempf, C; Knauf, F; Müller, D; Müller-Schlüter, K; Pfau, A	1
Daudon, M; Letavernier, E	2
Berthaud, R; Boyer, O; Dorval, G; Violier, P	1
Baud, L; Bouderlique, E; Chemaly, N; Daudon, M; Deschênes, G; Frochot, V; Haymann, JP; Huguet, L; Le Dudal, M; Letavernier, E; Martori, C; Nabbout, R; Perez, J; Tang, E; Vandermeersch, S	1

Reviews

1 review(s) available for stiripentol and Oxaluria, Primary

Article	Year
Stiripentol identifies a therapeutic target to reduce oxaluria. Current opinion in nephrology and hypertension, 2020, Volume: 29, Issue:4 Topics: Dioxolanes; Humans; Hyperoxaluria; Hyperoxaluria, Primary; L-Lactate Dehydrogenase; Oxalic Acid	2020

Other Studies

7 other study(ies) available for stiripentol and Oxaluria, Primary

Article	Year
New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production. European journal of medicinal chemistry, 2022, Jul-05, Volume: 237 Topics: Alcohol Oxidoreductases; Animals; Hyperoxaluria, Primary; L-Lactate Dehydrogenase; Liver; Mice; Oxalates; Salicylic Acid	2022
Stiripentol and Lumasiran as a Rescue Therapy for Oxalate Nephropathy Recurrence After Kidney Transplantation in an Adult Patient With Primary Hyperoxaluria Type 1. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2023, Volume: 82, Issue:1 Topics: Adult; Humans; Hyperoxaluria; Hyperoxaluria, Primary; Kidney Transplantation; Male; Middle Aged; Oxalates; Renal Insufficiency; RNA, Small Interfering	2023
Stiripentol for the treatment of primary hyperoxaluria and calcium oxalate nephropathy. Kidney international, 2020, Volume: 97, Issue:1 Topics: Calcium; Calcium Oxalate; Dioxolanes; Ethylene Glycols; Humans; Hyperoxaluria; Hyperoxaluria, Primary; Nephrolithiasis	2020
Stiripentol fails to lower plasma oxalate in a dialysis-dependent PH1 patient. Pediatric nephrology (Berlin, Germany), 2020, Volume: 35, Issue:9 Topics: Dioxolanes; Humans; Hyperoxaluria, Primary; Infant; Male; Oxalates	2020
[Effect of stiripentol on urine oxalate excretion]. Nephrologie & therapeutique, 2021, Volume: 17S Topics: Animals; Calcium Oxalate; Dioxolanes; Humans; Hyperoxaluria; Hyperoxaluria, Primary; Mice; Oxalates; Rats	2021
Treatment with stiripentol in a patient with primary hyperoxaluria type 1: lesson for the clinical nephrologist. Journal of nephrology, 2022, Volume: 35, Issue:3 Topics: Anticonvulsants; Dioxolanes; Humans; Hyperoxaluria, Primary; Nephrologists	2022
Stiripentol protects against calcium oxalate nephrolithiasis and ethylene glycol poisoning. The Journal of clinical investigation, 2019, 04-04, Volume: 129, Issue:6 Topics: Animals; Calcium Oxalate; Dioxolanes; Epilepsies, Myoclonic; Ethylene Glycol; Female; Hepatocytes; Humans; Hyperoxaluria, Primary; Kidney; Male; Nephrolithiasis; Rats; Rats, Sprague-Dawley	2019